How much funding has ABIONYX Pharma raised?

ABIONYX Pharma has raised $39.0M in total funding, most recently a corporate round round.

Where is ABIONYX Pharma headquartered?

ABIONYX Pharma is headquartered in Balma, France.

What industry is ABIONYX Pharma in?

ABIONYX Pharma operates in Biotech, Healthcare.

How many employees does ABIONYX Pharma have?

ABIONYX Pharma has 11-50 employees.

ABIONYX Pharma

Q: Who are ABIONYX Pharma's investors?

ABIONYX Pharma's investors include Sofinnova Partners, Alta Partners, EDF Ventures.

A new generation biotech company

Balma, France · $39.0M raised

Biotech

Healthcare

Headquarters: Balma
Employees: 11–50
Business Model: B2B
Website: abionyx.com

Total Funding: $39.0M
Last Round: $33.0M Corporate RoundMay 2026
Rounds: 5

About

ABIONYX Pharma is a next-generation biotech company developing innovative therapies for indications with no existing or effective treatment, including sepsis, renal disease, and ophthalmology. The company leverages bioengineered HDL nanoparticles and apoA-I-based platforms, including CER-001 and ABNX-100, as breakthrough biotherapeutics and targeted drug delivery vectors.

Summary

ABIONYX Pharma is a Biotech company based in Balma, France. It has raised $39.0M in total across 5 rounds, most recently a $33.0M Corporate Round round in May 2026. Investors include Sofinnova Partners, Alta Partners and EDF Ventures.